These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37094750)

  • 1. The efficacy of automated insulin delivery systems in children and adolescents with type 1 diabetes Mellitus: A systematic review and meta-analysis of randomized controlled trials.
    Michou P; Gkiourtzis N; Christoforidis A; Kotanidou EP; Galli-Tsinopoulou A
    Diabetes Res Clin Pract; 2023 May; 199():110678. PubMed ID: 37094750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72.
    Beck RW; Kanapka LG; Breton MD; Brown SA; Wadwa RP; Buckingham BA; Kollman C; Kovatchev B
    Diabetes Technol Ther; 2023 May; 25(5):329-342. PubMed ID: 37067353
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis.
    Benkhadra K; Alahdab F; Tamhane SU; McCoy RG; Prokop LJ; Murad MH
    Endocrine; 2017 Jan; 55(1):77-84. PubMed ID: 27477293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial.
    Abitbol A; Rabasa-Lhoret R; Messier V; Legault L; Smaoui M; Cohen N; Haidar A
    Diabetes Technol Ther; 2018 Mar; 20(3):189-196. PubMed ID: 29393675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Injections on Type 1 Diabetes Children: A Meta-Analysis of Randomized Control Trials.
    Qin Y; Yang LH; Huang XL; Chen XH; Yao H
    J Clin Res Pediatr Endocrinol; 2018 Nov; 10(4):316-323. PubMed ID: 30015622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
    Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
    JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative clinical efficacy and safety of insulin glargine 300 U/ml (Toujeo) versus insulin glargine 100 U/ml in type 2 diabetes and type 1 diabetes: A systematic literature review and meta-analysis.
    Joshi SR; Singh G; Marwah A; Mittra S; Suvarna VR; Athalye SN
    Diabetes Obes Metab; 2023 Jun; 25(6):1589-1606. PubMed ID: 36748186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.
    Foster NC; Beck RW; Miller KM; Clements MA; Rickels MR; DiMeglio LA; Maahs DM; Tamborlane WV; Bergenstal R; Smith E; Olson BA; Garg SK
    Diabetes Technol Ther; 2019 Feb; 21(2):66-72. PubMed ID: 30657336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.
    Ly TT; Brnabic AJ; Eggleston A; Kolivos A; McBride ME; Schrover R; Jones TW
    Value Health; 2014 Jul; 17(5):561-9. PubMed ID: 25128049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.
    Jeitler K; Horvath K; Berghold A; Gratzer TW; Neeser K; Pieber TR; Siebenhofer A
    Diabetologia; 2008 Jun; 51(6):941-51. PubMed ID: 18351320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Threshold-based insulin-pump interruption for reduction of hypoglycemia.
    Bergenstal RM; Klonoff DC; Garg SK; Bode BW; Meredith M; Slover RH; Ahmann AJ; Welsh JB; Lee SW; Kaufman FR;
    N Engl J Med; 2013 Jul; 369(3):224-32. PubMed ID: 23789889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achievement of metabolic control goals set by the American Diabetes Association and the International Society for Pediatric and Adolescent Diabetes in pediatric patients with type 1 diabetes from Spain.
    Enes P; Martín-Frías M; Álvarez MÁ; Yelmo R; Alonso M; Barrio R
    Diabetes Res Clin Pract; 2015 Feb; 107(2):300-5. PubMed ID: 25595220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional insulin dosing for fat and protein in children with type 1 diabetes using multiple daily injections.
    Frohock AM; Oke J; Yaliwal C; Edge J; Besser REJ
    Pediatr Diabetes; 2022 Sep; 23(6):742-748. PubMed ID: 35645222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Use of Open-Source Automated Insulin Delivery AndroidAPS in Full Closed-Loop Scenario: Pancreas4ALL Randomized Pilot Study.
    Petruzelkova L; Neuman V; Plachy L; Kozak M; Obermannova B; Kolouskova S; Pruhova S; Sumnik Z
    Diabetes Technol Ther; 2023 May; 25(5):315-323. PubMed ID: 36826996
    [No Abstract]   [Full Text] [Related]  

  • 17. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
    El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
    Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocol.
    Fuchs J; Allen JM; Boughton CK; Wilinska ME; Thankamony A; de Beaufort C; Campbell F; Yong J; Froehlich-Reiterer E; Mader JK; Hofer SE; Kapellen TM; Rami-Merhar B; Tauschmann M; Hood K; Kimbell B; Lawton J; Roze S; Sibayan J; Cohen N; Hovorka R;
    BMJ Open; 2021 Feb; 11(2):e042790. PubMed ID: 33579766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin Therapy and Diabetic Pregnancy.
    Napoli A
    Am J Ther; 2020; 27(1):e91-e105. PubMed ID: 31688066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait.
    Mohamed K; Al-Abdulrazzaq D; Fayed A; El Busairi E; Al Shawaf F; Abdul-Rasoul M; Shaltout AA
    J Pediatr Endocrinol Metab; 2019 Aug; 32(8):843-849. PubMed ID: 31318694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.